Scarica l'app Stockscreener
0.30
74.79%
-0.89
Dopo l'orario di chiusura:
.30
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ORGS Giù?
Forum
Previsione
Frazionamento azionario
Orgenesis Inc Borsa (ORGS) Ultime notizie
Patience Required for Orgenesis Investors as Strategic Model Takes Shape - AD HOC NEWS
The Truth About Orgenesis Inc (ORGS): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS
Orgenesis (NASDAQ:ORGS) Trading Up 300% – Here’s What Happened - Defense World
GLP-1 Receptor Agonist Market to Witness Massive Growth by 2033 | Perrigo Company PLC, 3M Company, Bausch Health - Weekly Voice
Orgenesis Issues Alpha Warrant in New Financing Deal - TipRanks
Orgenesis issues warrant for 3.29 million shares tied to $1 million loan - Investing.com
Orgenesis Signs Warrant Issuance Agreement With Alpha Prosperity Fund - TradingView
The Truth About Orgenesis (ORGS): Tiny Biotech, Massive Hype – But Should You Touch It? - AD HOC NEWS
Is Orgenesis Inc. (45O) stock a safe buy pre earnings2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда
Retail Trends: Is Orgenesis Inc 45O stock a safe buy pre earnings2025 Market WrapUp & AI Powered Buy/Sell Recommendations - moha.gov.vn
Aug Gainers: Is Orgenesis Inc 45O stock a safe buy pre earningsInflation Watch & Verified Swing Trading Watchlists - moha.gov.vn
Top Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant
Published on: 2025-12-23 22:10:30 - earlytimes.in
Regenerative Therapies Market Forecast Through 2032 - openPR.com
Statera Biopharma (NASDAQ:STAB) vs. Orgenesis (NASDAQ:ORGS) Financial Contrast - Defense World
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer - Business Wire
Is Oriental Culture Holding LTD a good long term investmentUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
Financial Contrast: Pharmaxis (OTCMKTS:PXSLY) and Orgenesis (NASDAQ:ORGS) - Defense World
What analysts say about GoPro Inc stockResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
How Orgenesis Inc. (45O) stock trades in high volatility2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Is Orgenesis Inc. (45O) stock suitable for passive index fundsWeekly Gains Report & Precise Swing Trade Alerts - Newser
Apex Tech Acquisition Inc files for IPO of up to $60 million - marketscreener.com
Is Orgenesis Inc. (45O) stock protected from inflation2025 Retail Activity & Fast Exit Strategy with Risk Control - Newser
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
How Orgenesis Inc. (45O) stock compares with top peersShort Setup & Accurate Entry/Exit Alerts - Newser
Why Orgenesis Inc. (45O) stock attracts HNW investorsJuly 2025 Final Week & Proven Capital Preservation Tips - Newser
Onconase (Ranpirnase) | Benefits and Side Effects - Mesothelioma.net
Will Orgenesis Inc. (45O) stock beat international competition2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Orgenesis (NASDAQ:ORGS) Stock Price Up 257.1% – Here’s Why - Defense World
Will Orgenesis Inc. (45O) stock gain from lower interest ratesProduct Launch & Verified Momentum Stock Alerts - newser.com
Is Orgenesis Inc. (45O) stock a buy during volatile marketsWeekly Trade Summary & Real-Time Sentiment Analysis - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
Why Orgenesis Inc. (45O) stock is a strong analyst pick2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsMarket Growth Report & Community Verified Trade Alerts - newser.com
1.18%
0.45%
Capitalizzazione:
|
Volume (24 ore):